Stay ahead of the competition with Reuters Business Insight strategic pharmaceutical and biotechnology management reports 

Stay ahead of the competition with Reuters Business Insight strategic management reports. Now with savings of up to $2,828

Reuters Business Insight is pleased to bring to you a Special End of Year Offer which includes many of their most successful healthcare management reports. The Special End of Year Offer comprises of two options, which will allow your company to benefit from substantial savings:

Choice 1: Order one report and get another report free - SAVING of $1199

Choice 2: Order any 5 reports - Normal Price $4875 - YOU PAY $2047 - SAVING of $2828

The following reports are included in the end of year offer:

• The Drug Discovery Outlook: Drivers of innovation in the 21st Century
• The Generics Outlook 2001
• The Blockbuster Drugs Outlook: Optimum management strategies throughout the product lifecycle
• eHealth Tools and eHealth Management: Opportunities and challenges for pharma companies and MCOs 
• Patient Power Outlook 2001
• Maximising the Drug Lifecycle
• Achieving Market Dominance Through Reformulation: A Strategic Insight
• The Japanese Pharmaceutical Market Outlook 2001
• The Pharmaceutical Mergers and Acquisitions Outlook 2001
• The Global Parallel Trade Outlook 2001-2006: A Country-by-Country Analysis
• Advertising medicines and providing health information on the Internet
• Strategic Intelligence: The Top 12 Pharmaceutical Companies
• The Genomics Outlook To 2005: Transforming pharmaceutical and diagnostic markets
• Next Generation Drugs: Acceleration Through Innovation
• The Pharmaceutical Industry Paradox
• Pharmaceutical Regulatory Affairs Outlook 2002: International strategies for faster drug approval

Using the pull down list select either the "2 for 1" or "5 report" selection.

To order these reports - click here! - then search by title or contact sales@bioportfolio.com